Astera Cancer Care East Brunswick — East Brunswick, New Jersey

Astera Cancer Care East Brunswick is a clinical research site located in East Brunswick, New Jersey, United States 08816-4096.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Astera Cancer Care East Brunswick has participated in 11 clinical trials with 9 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Advanced Non-Small Cell Lung Cancer.

Sponsors: Genentech, Inc., Hoffmann-La Roche, Mirati Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in East Brunswick

Browse all research sites in New Jersey · View every site in East Brunswick

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Astera Cancer Care East Brunswick?

Astera Cancer Care East Brunswick has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Astera Cancer Care East Brunswick conducted?

Astera Cancer Care East Brunswick has 11 clinical trials on record, with 9 currently active. Their work covers Chronic Lymphocytic Leukemia, Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer, Advanced Non-Small Cell Lung Cancer.

Is Astera Cancer Care East Brunswick accredited by Crixeo Clinical Trials?

Astera Cancer Care East Brunswick has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Astera Cancer Care East Brunswick?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.